(Journal Article): Limitations in Immunotherapy with CD3 Antibodies: Comment on the Article by Drs. Chatenoud and Bach
Bresson D, von Herrath M
IN:
Rev Diabetic Stud
2005; 20(4):187-189
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)
ABSTRACT: n.a. Click HERE for details